Covid: Oxford vaccine shows 'encouraging' immune response in older adults
Published
The phase two trial results raise hopes the jab can protect age groups most at risk from Covid-19.
Full ArticlePublished
The phase two trial results raise hopes the jab can protect age groups most at risk from Covid-19.
Full ArticleThe 40-year old volunteer, who works as a business consultant had wanted to investigate the cause of him contracting severe..
The COVID-19 vaccine created by AstraZeneca has reaped strong immune responses in adults from 56 to 69 years old and people over..